Enhancing Shared Decision-making to Guide Care for People With Dementia and Diabetes
Enhancing Shared Decision-making to Prompt and Guide Individualized Care for People With Alzheimer's Disease and Diabetes
Indiana University
62 participants
Jun 7, 2023
INTERVENTIONAL
Conditions
Summary
Aim 1: Characterize shared decision-making and unmet patient-caregiver dyads needs for patients with diabetes and Alzheimer's Disease and related dementias (ADRD) while using a continuous glucose monitoring (CGM) device. Aim 2: Develop an interactive tool to enhance shared decision-making for diabetes management.
Eligibility
Inclusion Criteria14
- patient must have dual diagnosis of MCI or ADRD and diabetes (DM)
- patient must have active prescriptions for DM
- patient must have had at least one visit to an Eskenazi or IU Health primary care clinic within 12 months
- patient must be able to provide assent and have a legally authorized representative (LAR) consent on their behalf if patient lacks capacity to consent
- patient must have a caregiver aged 18 years or older who interacts daily, or almost daily, with the patient
- patient and caregiver must both speak English
- patient and caregiver must both reside in the community
- dyad must have internet access
- primary care physicians
- nurses
- pharmacists
- nutritionists
- psychologists
- medical residents
Exclusion Criteria11
- patient has terminal illness
- use of an automated insulin delivery system
- patient is receiving dialysis
- patient is taking ascorbic acid during monitoring period
- patient has existing implanted medical devices
- patient has a bleeding disorder
- patient has a pre-existing arm skin lesions
- patient has an allergy to medical adhesive or isopropyl alcohol
- patient has plans for imaging or diathermy treatment during the study period
- only treats patients younger than 65 years
- does not manage patients' DM
Interventions
CGM education and glucose data collection for 14 days with a device. Interviews with dyads to assess experience and awareness of hypoglycemic events.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05643144